Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Houlind

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|July 2, 2015
Hard endpoints from large randomized, clinical trials are more important than early reports of surrogate endpoints from small studiesKim Houlind
Future Cardiology|April 26, 2014
On ROOBY trial data and the impacts of revascularization: reply from the authorKim Houlind
Future Cardiology|October 3, 2017
Reviewing the extended RCT follow-up data for on-pump versus off-pump coronary artery bypass surgeryKim Houlind
Future Cardiology|July 10, 2013
On-pump versus off-pump coronary artery bypass surgery: what is the status after ROOBY, DOORS, CORONARY and GOPCABE?Kim Houlind
Diabetes/Metabolism Research and Reviews|December 17, 2019
Surgical revascularization and reconstruction procedures in diabetic foot ulcerationKim Houlind
Ugeskrift for Laeger|August 5, 2015
[Angiosome-directed revascularization of critical limb ischaemia]Kim Houlind
Ugeskrift for Laeger|September 21, 2019
Kim Houlind
The Journal of Thoracic and Cardiovascular Surgery|April 25, 2015
Benefits of OPCAB are not for everybody. Costs areKim Houlind
Scandinavian Cardiovascular Journal : SCJ|November 9, 2013
OPCAB surgery is cost-effective for elderly patientsKim Houlind, Lars Ehlers
The Journal of Thoracic and Cardiovascular Surgery|April 2, 2015
Definition of proximal anastomosis in the doors studyKim Houlind, Bo Juel Kjeldsen
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Thoracic and Cardiovascular Surgery|July 2, 2015
Hard endpoints from large randomized, clinical trials are more important than early reports of surrogate endpoints from small studiesKim Houlind
Future Cardiology|April 26, 2014
On ROOBY trial data and the impacts of revascularization: reply from the authorKim Houlind
Future Cardiology|October 3, 2017
Reviewing the extended RCT follow-up data for on-pump versus off-pump coronary artery bypass surgeryKim Houlind
Future Cardiology|July 10, 2013
On-pump versus off-pump coronary artery bypass surgery: what is the status after ROOBY, DOORS, CORONARY and GOPCABE?Kim Houlind
Diabetes/Metabolism Research and Reviews|December 17, 2019
Surgical revascularization and reconstruction procedures in diabetic foot ulcerationKim Houlind
Ugeskrift for Laeger|August 5, 2015
[Angiosome-directed revascularization of critical limb ischaemia]Kim Houlind
Ugeskrift for Laeger|September 21, 2019
Kim Houlind
The Journal of Thoracic and Cardiovascular Surgery|April 25, 2015
Benefits of OPCAB are not for everybody. Costs areKim Houlind
Scandinavian Cardiovascular Journal : SCJ|November 9, 2013
OPCAB surgery is cost-effective for elderly patientsKim Houlind, Lars Ehlers
The Journal of Thoracic and Cardiovascular Surgery|April 2, 2015
Definition of proximal anastomosis in the doors studyKim Houlind, Bo Juel Kjeldsen
Pageof 6